BWBeverly Wuertz

Beverly Wuertz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Beverly Wuertz has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A novel method using electronic health record coding to generate a unique, multipurpose database for aerodigestive malignancy surveillance

    by Lindsey Mortensen, Alexander Dwyer, Benjamin Palatnik, Beverly R Wuertz, Frank G Ondrey

  • Head and Neck Cancer Research Training Program Associated with Academic Success for Trainees

    by Aanish Puri, Andrew C. Elton, Beverly R. Wuertz, Frank G. Ondrey

    This study is to analyze academic success metrics of otolaryngology cancer research laboratory trainees. This is a retrospective analysis of trainee academic outcomes from 2000 to 2020. We examined careers of 99 trainees of the senior author’s cancer research laboratory, including undergraduates, medical students, otolaryngology residents/fellows, and NIH T32 postdocs. We compared medical school matriculation rates, otolaryngology and head and neck surgery (OHNS) residency match rates, fellowship match rates, publication rates, and academic positions with publicly available data from the American Association of Medical Colleges (AAMC), National Resident Matching Program (NRMP), and others. Nine undergraduates achieved a 100% medical school matriculation rate compared with the AAMC rate of 43.4%. Of 22/53 medical students who applied to OHNS residency, students achieved a 100% match rate, compared with the NRMP match rate of 82.1%. Of 33 medical students who completed training, 45.4% became academicians, compared with 44.9% in an NIH R25E program cohort, which is notable. Interestingly, medical student trainees overall had more publications compared with incoming OHNS residents. Our residents achieved a 100% fellowship match rate compared with 79.0% average match rate across OHNS fellowship programs. Twelve of 25 (48%) residents earned advanced degrees (10 MS, 2 PhD), 11 of which were directly related to oncology. This was statistically significant compared to incoming otolaryngology residents via the NRMP data. Sixty percent (3/5) of surgical fellows entered academics. We observed multiple benefits from participation in our research laboratory at all levels of academic cancer training, specifically medical school and otolaryngology residency matriculation and academic faculty placement of former trainees.

  • Analysis of nuclear receptor expression in head and neck cancer

    by Lindsey Mortensen, Cynthia K. Koenigsberg, Tyler G. Kimbrough, Jesse Ping, Gema Souto Adeva, Beverly R. Wuertz, Patrick Gaffney, Frank G. Ondrey


  • Open Access

    Modeling Epithelial Homeostasis and Perturbation in Three-Dimensional Human Esophageal Organoids

    by Masataka Shimonosono, Masaki Morimoto, Wataru Hirose, Yasuto Tomita, Norihiro Matsuura, Samuel Flashner, Mesra S. Ebadi, Emilea H. Okayasu, Christian Y. Lee, William R. Britton, et al.

    Background: Esophageal organoids from a variety of pathologies including cancer are grown in Advanced Dulbecco’s Modified Eagle Medium-Nutrient Mixture F12 (hereafter ADF). However, the currently available ADF-based formulations are suboptimal for normal human esophageal organoids, limiting the ability to compare normal esophageal organoids with those representing a given disease state. Methods: We have utilized immortalized normal human esophageal epithelial cell (keratinocyte) lines EPC1 and EPC2 and endoscopic normal esophageal biopsies to generate three-dimensional (3D) organoids. To optimize the ADF-based medium, we evaluated the requirement of exogenous epidermal growth factor (EGF) and inhibition of transforming growth factor-(TGF)-β receptor-mediated signaling, both key regulators of the proliferation of human esophageal keratinocytes. We have modeled human esophageal epithelial pathology by stimulating esophageal 3D organoids with interleukin (IL)-13, an inflammatory cytokine, or UAB30, a novel pharmacological activator of retinoic acid signaling. Results: The formation of normal human esophageal 3D organoids was limited by excessive EGF and intrinsic TGFβ-receptor-mediated signaling. Optimized HOME0 improved normal human esophageal organoid formation. In the HOME0-grown organoids, IL-13 and UAB30 induced epithelial changes reminiscent of basal cell hyperplasia, a common histopathologic feature in broad esophageal disease conditions including eosinophilic esophagitis. Conclusions: HOME0 allows modeling of the homeostatic differentiation gradient and perturbation of the human esophageal epithelium while permitting a comparison of organoids from mice and other organs grown in ADF-based media.


  • Open Access

    Modeling epithelial homeostasis and perturbation in three-dimensional human esophageal organoids

    by Masataka Shimonosono, Masaki Morimoto, Wataru Hirose, Yasuto Tomita, Norihiro Matsuura, Samuel Flashner, Mesra S. Ebadi, Emilea H. Okayasu, Christian Y. Lee, William R. Britton, et al.

    Background: Esophageal organoids from a variety of pathologies including cancer are grown in Advanced Dulbecco’s Modified Eagle Medium-Nutrient Mixture F12 (hereafter ADF). However, the currently available ADF-based formulations are suboptimal for normal human esophageal organoids, limiting the ability to compare normal esophageal organoids with those representing a given disease state. Methods: We have utilized immortalized normal human esophageal epithelial cell (keratinocyte) lines EPC1 and EPC2 and endoscopic normal esophageal biopsies to generate three-dimensional (3D) organoids. To optimize ADF-based medium, we evaluated the requirement of exogenous epidermal growth factor (EGF) and inhibition of transforming growth factor-(TGF)-β receptor-mediated signaling, both key regulators of proliferation of human esophageal keratinocytes. We have modeled human esophageal epithelial pathology by stimulating esophageal 3D organoids with interleukin (IL)-13, an inflammatory cytokine, or UAB30, a novel pharmacological activator of retinoic acid signaling. Results: The formation of normal human esophageal 3D organoids was limited by excessive EGF and intrinsic TGFβ receptor-mediated signaling. In optimized HOME0, normal human esophageal organoid formation was improved, whereas IL-13 and UAB30 induced epithelial changes reminiscent of basal cell hyperplasia, a common histopathologic feature in broad esophageal disease conditions including eosinophilic esophagitis. Conclusions: HOME0 allows modeling of the homeostatic differentiation gradient and perturbation of the human esophageal epithelium while permitting a comparison of organoids from mice and other organs grown in ADF-based media.

  • Open Access

    Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality

    by Seth Buryska, Ketan Patel, Beverly Wuertz, Patrick M. Gaffney, Frank Ondrey

    Background/Aim: Activin, a member of the TGF-β super family of cytokines, is involved in head and neck squamous cell carcinoma (HNSCC). This study examined the constituents of the activin axis in order to further elucidate the role of activin A in HNSCC progression. Materials and Methods: Immunohistochemistry (IHC), reverse transcription polymerase chain reaction (RT-PCR), MTT, and matrigel invasion assays, in addition to analysis of the tumor cancer genome atlas (TCGA), were employed. Results: IHC in HNSCC and oral leukoplakia (OPL) lesions demonstrated increased expression of the inhibin subunit βA (INHBA) (p<0.0001), as well as activin receptor type IB (ACVR1B) (p<0.0032) compared to normal mucosa. TCGA analysis revealed increased INHBA expression was associated with lymph node positive tumors (p=0.024), decreased overall survival (p=0.0167), and decreased promoter methylation (p<0.0001). Concomitant up-regulated expression of gene pathways strongly correlated with INHBA expression demonstrated further deleterious effects on survival (p<0.0148). Conclusion: Activin may be an important component of early carcinogenesis in OPL and HNSCC with unfavorable effects on clinical end-points such as survival.


  • Open Access

    Abstract 6306: Genomic analysis markers of stemness in oral cancer progression

    by Gretchen Unger, Beverly G Wuertz, Patrick J Gaffney, Frank G. Ondrey

    Introduction: In clinical cancer treatment there is an continuing effort to identify limited gene sets from high dimensional data to predict risk, treatment response, etc. Oral carcinogenesis is a multistep process of mutations, disordered growth, and the development of invasion. In the oral cancer milieu, inflammation and stemness has been demonstrated to be cooperative during carcinogenesis. We hypothesized that differences in inflammation, stemness, and EMT might distinguish lesion and adjacent normal mucosa in our RNA Seq data on preneoplastic lesions. Once candidate genes are identified they might be applied to other oral mucosal specimens to identify risk for malignancy development. Materials and Methods: We collected lesion and adjacent normal mucosal tissues from 16 subjects with high risk leukoplakia and early oral cancer (T1N0 and T2N0). Sequencing libraries were generated using the Illumina Truseq Stranded mRNA library prep kit. Sequencing was performed on an Illumina Hiseq 3000 instrument with paired-end 75bp read and sequenced to an overall depth of 30 million reads per sample. Results: After developing a biospecimen collection procedure that functions in the senior author’s clinic flow, we were able to isolate sequenceable total RNA from 100% of the specimens we collected. We identified several hundred differentially expressed genes between lesion and adjacent normal. With regard to stemness, inflammation, and EMT we multiple candidate genes that could be incorporated into a limited gene set for further studies. Aldehyde dehydrogenase family members were of particular interest in the stemness candidate genes, for example. ALD 1A1 and ALD 3B1, were significantly upregulated in lesion versus normal (P< 0.02). Conclusions: We conclude there are differentially expressed inflammatory, EMT, and stemness in oral preneoplastic specimens. We have identified multiple candidate genes that could be assembled into a limited gene panel (12-24 genes) for further studies of oral cancer risk in mucosal lesions

  • Open Access

    Genomic analysis points to fibrosis and changes in fat metabolism in oral cancer progression

    by Gretchen Unger, Beverly R Wuetz, Charles L Pruett, Matthew J Watkins, Patrick M. Gaffney, Frank G. Ondrey

    Head and neck cancer long term survival has only experienced marginal gains over the past 3 decades. Further, there is inadequate understanding of the biology of carcinogenesis and recurrence, as well as its relation to the microenvironment. Deeper understanding of these areas would provide improved molecular target identification. In pursuit of this goal, a small clinical trial collected lesion and adjacent normal-appearing mucosa for subsequent RNA-seq analysis. Patients were grouped by post-surgical pathology as either precancer (hyperplasia - severe dysplasia) or cancer (carcinoma in situ - early stage invasive cancer). Following identification of differentially expressed (DE) genes, DE genesets were submitted for Ingenuity Pathway Analysis (IPA). Hierarchical clustering illustrates distinct separation between lesion and perilesional normal mucosa of the top 100 DE genes. Among the top 25 dysregulated pathways, 50% were associated with creation of fibrotic tumor microenvironment (TME), 20% were related to changes in immune populations inhabiting the TME and 10% devoted to metabolism changes. Subgroup analysis, (precancer vs. cancer), revealed dysregulation of metabolism (~50%) predominating in precancer. Metabolism remained an important dysregulation at 30% of the top 25 pathways in cancer. Protein network analysis, (Metascape on-line tool), confirmed IPA results, illustrating an extensive, previously undescribed, interconnectedness of fibrosis with shifts in fatty acid metabolism from oxidative to gluconeogenesis, providing a foundation for choosing targets amenable to cancer prevention. Several notable pathways are likely contributed to by inflammatory and other cells in the milieu, not precancer cells themselves. So, we dove deeper, using EpIC (Epitope Immunogenicity Characterization) algorithm to assess relative percentages of non-tumor cells based on 20-count gene signatures. Gene expression favored a profile of significantly increasing cancer-associated fibroblasts, decreasing CD-8 killer T cells, and increasing vascular endothelial cells during progression, with macrophage content slightly increasing in cancer specimens. These findings suggest interaction between immunoinflammatory milieu and precancerous cells promoting malignancy. Several high yield target pathways are related to published mechanisms of action for drugs of high interest to our cancer prevention program (pioglitazone/metformin). Further, we confirmed protein network analysis in an additional oral carcinoma dataset from Conway et. al, (Oncotarget 2015; doi: 10.18632/oncotarget.5529). Abstract 2590

  • Open Access

    Abstract PO-011: Analysis of nuclear receptor expression in head and neck cancer

    by Lindsey Mortensen, Beverly R. Wuertz, Frank G. Ondrey

    Background: The nuclear receptor (NR) superfamily contains a wide array of transcription factors responsible for cellular metabolism, inflammation, differentiation, and hormonal functions. For 45 years these receptors have been of interest in head and neck squamous cell carcinoma (HNSCC) treatment and prevention, especially retinoic acid receptor (RAR), peroxisome proliferator-activated receptor (PPAR), and vitamin D receptor (VDR) families. In the current study we examined expression patterns of these receptors in The Cancer Genome Atlas (TCGA). Methods: TCGA RNA-Seq data within the cBioportal platform comparing HNSCC samples (n=515 patients/samples) to normal tissue (n=82 patients/samples) was interrogated for significant differences in nuclear receptor expression. Genes with a z-score relative to normal samples (log RNA-Seq V2 RSEM normalized) greater than +2 or less than -2 in ≥50% of cases were considered significant. Unpaired, two-tailed t-tests were used to analyze comparisons in nuclear receptor genes’ z-scores across multiple clinical and pathologic parameters, pPPARγ) and Retinoic Acid Receptor Related Orphan Receptor C (RORC) (both in the thyroid hormone receptor-like family), and the NR cofactor, Nuclear Receptor Coactivator 1 (NCOA1), were differentially expressed and downregulated in tumors compared to normal tissue. Differences in specific NR expression varied significantly with HPV status (30 NRs), organ site (oral cavity vs hypopharynx & larynx; 20 NRs), tumor size (T1/2 vs. T3/4; 21 NRs), gender (male vs. female; 7 NRs); tumor staging (stage I/II vs. stage III/IV; 6 NRs); lymph node status (N0 vs. N+; 5 NRs), smoking history (smokers vs. non-smokers; 3 NRs), and patient race (White vs. Black/African American; 2 NRs). Conclusions: In prior studies of nuclear receptors in aerodigestive cancer, the retinoid receptor axis was downregulated, and a subsequent goal was stimulation and restoration of activity with natural or synthetic retinoids as a rationale for treatment. Presently, we have discovered significant decreases in PPARγ expression and are targeting this receptor with thiazolidinediones in a series of preclinical and human trials in a similar rationale to promote restoration of normal signaling and events like maturation. Here, we observed significant differences in a variety of parameters of several receptors associated with risk factors, stage, race, and gender that are observed and may become the focus of interest in future targeting efforts. Citation Format: Lindsey Mortensen, Beverly R. Wuertz, Frank G. Ondrey. Analysis of nuclear receptor expression in head and neck cancer [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-011.

  • Open Access

    Abstract PO-010: Operationalizing the health care system electronic medical record to create head and neck cancer research and screening databases

    by Lindsey Mortensen, Alexander J. Dwyer, Beverly R. Wuertz, Frank G. Ondrey

    Introduction: A “living” prospective database for tracking patient outcomes and creating clinical trial screening populations would be useful for head and neck multidisciplinary teams and can be translated to innumerable populations of interest. The database should be rapidly accessible, economical, accurate, and transcend the typical 5-year length of grants. We hypothesized we could construct such a database and piloted the concept using patients within our head and neck cancer active surveillance population. This population consists of patients at high risk for the development of primary and secondary oral carcinoma over 20 years. A second goal was identifying subjects for oral leukoplakia studies and construction of genomic atlases. Methods: Through the University of Minnesota Clinical and Translational Sciences Institute (CTSI), we performed an IRB interrogation of our patient population in the EPIC electronic medical record (EMR) of 4,496 unique patients seen by the senior author and identified 1,375 unique deidentified patient records representing individuals with likely preneoplastic lesions. Our approach included 30 International Classification of Disease (ICD) 9 and 10 codes corresponding to 120 unique mucosal head and neck precancerous lesion descriptors. Information included typical demographic and risk data, laboratory, pathology, and possible staging data. All curated data were stored on CTSI servers with direct access to data analysis software. Results: The ICD 9 and 10 codes queried encompass 36 low risk, 16 moderate/low risk, 8 moderate/high risk, and 55 high risk lesion codes. 25/30 of the queried ICD 9 and 10 codes (>12,000 instances) were identified in the 4,496 patients queried, encompassing 1,375 unique patients, with most patients harboring multiple ICD codes. We identified 464 patients with diagnosed high risk lesions, 346 with moderate/high risk lesions, 692 with moderate/low risk lesions, and 728 with low-risk lesions. Several research functions in the EMR were identified to construct screening lists. From IRB approval to obtaining the data set from the CTSI, this process requires fewer than 24 hours of combined labor, minimal cost, and did not require manual chart abstraction. Conclusions: From our preliminary success in curating a dataset of patients diagnosed with high-risk oral lesions, we conclude that utilization of ICD 9 and 10 codes as inclusion criteria represents an efficient and simple way for busy practitioners to screen large amounts of clinical data for study populations of interest (>1 × 106 EMR). We will develop quality assurance and improvement measures to audit data accuracy. Further expansion of this work will apply similar algorithmic dataset curation to medical records acquired from clinicians beyond the current study population. Critically, this process could be used for a variety of conditions to develop comprehensive longitudinal databases to examine both retrospective and prospective outcomes, provided an ICD 9 or 10 code exists for the condition and coding is accurate and consistent. Citation Format: Lindsey Mortensen, Alexander J. Dwyer, Beverly R. Wuertz, Frank G. Ondrey. Operationalizing the health care system electronic medical record to create head and neck cancer research and screening databases [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-010.